About Us

We are a team of hardworking professionals combining our backgrounds in digital marketing, technology, healthcare and finance to give consumers on demand access to better healthcare products and virtual care.

Management Team

Justin Schreiber

Chairman & CEO

As a co-founder of LifeMD, Justin Schreiber has played an essential role in the company’s formation, growth, and development. He has served as CEO and Chairman of the board of directors since 2018.

Justin is an experienced venture investor, and the founder and president of JLS Ventures. He previously worked for a global healthcare consulting firm where he gained experience in operations design and effectiveness, efficiency improvements, and supply chain optimization. He began his career at Gain Capital Group, focused on foreign currency trading.

Justin holds a B.S. in International Business from Elizabethtown College and a B.A. in International Management from the ICN École de Management in Nancy, France.

Stefan Galluppi

Chief Innovation Officer

Stefan Galluppi brings to LifeMD more than a decade of experience in building technology platforms for direct-to-consumer marketing campaigns. He has served as LifeMD’s Chief Technology Officer since co-founding the company in 2016.

Stefan previously served as Chief Technology Officer of Runaway Products, a DRTV driven marketing firm with a core focus on building and optimizing systems to scale marketing campaigns for maximum efficiency and profitability. Stefan co-founded NT1, a digital marketing, web development, and design company that built, scaled, and managed a variety of DTC brands. He previously served as a commodities trader at CQR Capital and held Series 3, 63, and 55 licenses.

Marc Benathen

Chief Financial Officer

Marc Benathen brings to LifeMD more than 18 years of financial, strategy, direct-to-consumer, and operating leadership experience. He has served as LifeMD’s Chief Financial Officer since 2021.

Marc previously served as SVP and Chief Financial Officer for Blink Fitness, a national health and wellness brand, where he oversaw Finance, Accounting, Financial Operations, Procurement, Legal, and Member Services. Prior to this, Marc held several senior financial and operating positions with ANN, Inc, the then public company parent of Ann Taylor, LOFT, and Lou & Grey. Earlier in his career, Marc held finance and strategy positions of increasing responsibility across both publicly traded and high growth private equity owned companies.

Marc holds a BBA, Finance (Honors) from Baruch College.

Dennis Wijnker

Chief Technology Officer

Dennis has over 20 years of experience in Software Development, filling positions of technical and managerial leadership.

He has extensive experience building web-based and standalone platforms, primarily in the fields of Health Care and Life Sciences. Dennis joins LifeMD from Doctor Evidence where he worked as Senior Architect and Senior Vice President of Technology with various teams to create innovative solutions bringing analytics and insights powered by AI to the field of Evidence-based medicine. He also held leadership positions at Parexel/Perceptive Informatics (now Calyx) where amongst others he developed a web-based fully configurable Electronic Data Capture platform for managing clinical trials that enjoyed wide adoption in the industry. He was also instrumental in introducing and implementing clinical data standards to connect said platform with other technologies used in clinical trials. Prior to focusing on technology, Dennis studied Bio-Pharmaceutical Sciences at Leiden University (Leiden, The Netherlands). His hobbies include road biking, travel/adventure with his family and playing the piano.

Nick Alvarez

Chief Acquisition Officer

Nick Alvarez is an accomplished executive in the digital marketing space, responsible for overseeing LifeMD's customer acquisition efforts, including its advertising strategy and media buying. He has served as LifeMD’s Chief Acquisition Officer since 2018.

Nick previously served as the head media buyer at Cheviot Capital and as a digital marketing specialist at Internet Brands, where he was responsible for brands including Lawyers.com and Carsdirect.com with more than $100 million in paid media budgets. He is a certified Facebook and Google marketing professional.

Nick holds a B.A. in Entrepreneurship from Loyola Marymount University.

Jessica Friedeman

Chief Marketing Officer

Jessica Friedeman is a healthcare executive with a proven track record of employing strategy, data, and technology to successfully scale forward-thinking, high growth companies.

Jessica previously managed the strategic planning processes for a multitude of health systems, resulting in recruitment by Northwest Community Healthcare to run business development efforts internally. Jessica then joined Truven Healthcare (now IBM Watson Health) where she oversaw the Healthcare Marketing and Planning business lines. Jessica later joined Evariant, where she led Solutions Engineering and Product marketing functions. Jessica’s focus on solution packaging and positioning actively contributed to Evariant’s acquisition by Healthgrades.

Following Evariant’s acquisition, Jessica joined Healthgrades as EVP, Chief Marketing Officer. In this latest role - defined by three company transactions in less than three years - she assimilated messaging and product portfolios from multiple prior acquisitions to amplify the Healthgrades brand, drove the end-to-identity creation of Mercury Healthcare in tandem with the divestiture of the Healthgrades B2C division, and optimized sales execution with a focus on market fit that was integral in the acquisition of Mercury Healthcare by WebMD.

Jessica graduated Magna Cum Laude from Middlebury College with a BA in Neuroscience and minor in Economics.

Gerard Rotonda |||

Managing Director, Strategy and Business Development

Gerard Rotonda III brings to LifeMD more than 25 years of strategic, financial, and operating leadership experience. He serves as LifeMD’s Managing Director of Strategy & Business Development.

Gerard was Chief Financial Officer for Deutsche Bank, Wealth and Asset Management, and as CFO he oversaw Finance, Accounting, and Strategy. He currently serves on the Board of Directors of Digihost Technology (DGHI). Gerard was CEO of online pharmacy GoGoMeds and also has held several senior leadership positions at MasterCard Worldwide (MA), Credit Suisse (CS), and Citigroup (C). Gerard began his career as an Auditor and Tax Accountant at Arthur Andersen LLP.

Gerard holds a BSBA (Accounting) and M.B.A. from Boston University, receiving a U.S. Secret Service Scholarship for heroism. He also served as Treasurer and Board Member of The Jericho Project, a nonprofit helping to end homelessness for Veterans and NYC residents. He has earned the Distinguished Eagle Scout Award and actively supports The Boy Scouts of America.

Maria Stan

Principal Accounting Officer

Maria Stan, is an accomplished financial executive with 20 years of experience in accounting and finance, operational advisory, and international relations. She has served as LifeMD's Vice President and Controller since 2021 and as Principal Accounting Officer since 2022.

Prior to joining LifeMD, Maria was a Director in the accounting and advisory practice of Eventus Advisory Group, a Boutique CFO solutions firm focused on structuring financial and accounting processes. Maria served as the Chief Financial Officer of a privately held international hospitality services conglomerate where she oversaw finance, accounting, procurement, and operations. She also held the position of Vice President and Controller for Kaplan North America, a subsidiary of Graham Holdings Company, a NYSE-listed company, with operations in the US, Latin America, Europe, and Asia

Maria's career started in public accounting at Ernst & Young where she ascended to Manager. She then moved to KPMG where her ascension continued to Senior Manager in the audit and advisory practice. Maria speaks three languages including English, Spanish, and Portuguese. She is a Certified Public Accountant and earned her B.S. in Accounting from the City University of New York at Brooklyn College.

Eric Yecies

Chief Legal Officer & General Counsel

Eric Yecies is an accomplished trial and transactional attorney with more than 16 years of experience practicing law in the life sciences space. He has served as LifeMD’s General Counsel and Chief Legal Officer since 2020.

Eric was previously a partner at Holland & Knight, a top ranked national law firm where he served as a member of the firm's Intellectual Property group and grew its New York IP Group from inception. Eric specializes in patent, trade secret, trademark, false advertising, anti-competitive, counterfeiting, and regulatory cases across a broad range of technical disciplines. Prior to Holland & Knight, Eric was a senior patent litigation associate at Goodwin Procter, where he was responsible for running day-to-day strategy and management of billion-dollar IP cases, as well as negotiating settlement and licensing agreements on behalf of life science companies.

Eric received his Doctor of Law, specializing in intellectual property, from the New York University School of Law. He received his B.A. and M.A. in biology, molecular concentration, from the University of Pennsylvania. He regularly speaks and publishes about intellectual property law.

Shane Biffar

Chief Compliance Officer & Deputy General Counsel

Shane Biffar is an experienced in-house attorney and compliance professional with over 15 years of legal and regulatory compliance experience, having joined LifeMD in June 2023 after spending five years as the General Counsel, Privacy Officer, and Head of Compliance at Heuro Health, a B2B telehealth company. At Heuro, in addition to managing the legal function, Shane led HIPAA compliance and data privacy efforts in close collaboration with the company’s technology and information security teams. He also collaborated closely with company engineers, vendors, partners, and leadership to ensure the regulatory-compliant development and implementation of the company’s proprietary technology and third party integrations.

Shane also has extensive experience navigating legal issues faced by growing technology companies, including negotiation of complex commercial agreements, contract management, dispute resolution, and overall risk management. He brings to this role his familiarity with privacy law, HIPAA, risk assessment standards, and third-party risk management, as well as his general familiarity with laws and regulations applicable to the telehealth space. Shane began his career as a litigator and spent 10 years in private practice in the litigation departments of various New York law firms, including Greenberg Traurig LLP, Day Pitney LLP, and Blank Rome LLP.

Shane completed the Honors Program at the University of Maryland, College Park, graduating with a B.A. in Psychology. He received his law degree from Brooklyn Law School, where he was a Richardson Merit Scholar.

James Porte

SVP of Patient Experience

James Porte brings to Life MD over 15 years of experience in sales and call center operations.

James previously served as General Manager of Sales and Customer Retention at DISH Network where he built a successful team of sales professionals focused on increasing customer retention. He was part of a team that built DISH's retention department from the ground up leading them to a best in class JD Power award in customer service.

James holds a B.S. in Business and Technology from Middle Tennessee State University.

Anthony Puopolo, MD

President, LifeMD Affiliated P.C.s

Anthony Puopolo, MD brings to LifeMD more than 20 years of executive and professional healthcare experience, including serving in senior leadership positions at several medical institutions and organizations. He has served as LifeMD’s Chief Medical Officer since 2021.

Dr. Anthony most recently served as the regional medical director for SwiftMD, which provides personalized telemedicine services to individuals, groups, and employers. Dr. Puopolo founded Integrative Wellness Medical Group where he specialized in wellness coaching, pharmacological management, and psychotherapy. He previously served as a physician at Sharp Rees Stealy Medical Group. Dr. Anthony earlier served in several positions at 121 General Hospital in South Korea, including chief of inpatient psychiatric ward, medical director of its alcohol treatment center, and family practice staff physician. As an Army Major, he served as the chief psychiatrist and officer-in-charge at the U.S. Army’s Camp Casey Troop Medical Clinic in South Korea, which provided mental health services to the 2nd Infantry Division.

Dr. Anthony earned his B.A. in Biology from Tufts University, M.A. in Biology from Boston University, and Doctor of Medicine from the Boston University School of Medicine. He completed his residency at the Tripler Army Medical Center. Dr. Puopolo completed an intensive wellness fellowship at the Andrew Weil Center for Integrative Medicine at the University of Arizona. Dr. Puopolo is a member of the American Board of Family Medicine and Eye Movement Desensitization Reprocessing International Association (EMDRIA).

Board Members

Justin Schreiber


As a co-founder of LifeMD, Justin Schreiber has played an essential role in the company’s formation, growth, and development. He has served as CEO and Chairman of the board of directors since 2018.

Justin is an experienced venture investor, and the founder and president of JLS Ventures. He co-founded and currently serves on the board of Quantum Computing Inc. (OTCQB:QUBT), a technology leader for quantum-ready applications and software tools. He previously worked for a global healthcare consulting firm where he gained experience in operations design and effectiveness, efficiency improvements, and supply chain optimization. He began his career at Gain Capital Group, focused on foreign currency trading.

Justin holds a B.S. in International Business from Elizabethtown College and a B.A. in International Management from the ICN École de Management in Nancy, France.

John Strawn


John Strawn brings to the LifeMD board more than 25 years of legal experience, including extensive knowledge and understanding of the company’s intellectual property portfolio. He has successfully represented his practice for over 10 years, focusing on commercial litigation and disputes over the IP ownership and patent licensing. John is a founding partner of Strawn Pickens and was the co-managing partner of Cruse Scott Henderson & Allen, both based in Houston, Texas. John received his Juris Doctor from the University of Texas Law School and his bachelor’s degree from Dartmouth College.

Joseph V. DiTrolio, MD


Dr. Joseph DiTrolio is a recognized inventor, researcher, lecturer and clinical professor of urology at UMDNJ. He is a clinical professor of surgery in the Urology division at New Jersey Medical School and the holder of several surgical-related patents. He also serves on the board of Stone Center of New Jersey. Dr. DiTrilio earlier served as the medical director of Unitron Medical Communications and chairman of the urology department at Saint Barnabas Medical Center. He received undergraduate degrees from the University of Richmond and Paris-Sorbonne University Abu Dhabi, and his doctorate from New Jersey Medical School.

Naveen Bhatia


Naveen Bhatia is a private investor. From 2013 to 2020, he was a Senior Director in the Tactical Opportunities Group of Blackstone, a leading global investment business specializing in alternative asset classes.

Before joining Blackstone, Naveen was a Managing Director at 40 North Industries LLC, a private investment firm where he focused on special situations equity and debt investments, both public and private. Prior to 40 North, he was a Principal at a family office in New York. From 2003 to 2008, Naveen was a Co-Founder and Partner of Eagle Lake Capital LLC, a private investment partnership focused on fundamental, value investing across the capital structure. He started his career as a member of the Restructuring Group at Rothschild.

Naveen received a BA in Public Health from The Johns Hopkins University. He has served as a director of various public and private companies, currently serving as a member of the Board of Directors of Blue Yonder, EquipmentShare, RG Barry, and CRG Financial. From 2010-2019, Naveen served as Chairman of the Board of Cotton Holdings, a leading global infrastructure support services company. He was also an Adjunct Professor at Columbia Business School and taught Applied Security Analysis I & II for eight years.

Roberto Simon


A seasoned, global executive, Roberto Simon has held several senior leadership roles over the last 19 years, where he has managed the organic and acquisitive growth for large, international firms operating across the Americas, Europe and Africa. He currently serves as CFO of WEX (NYSE:WEX), a $6+ billion fintech services provider. He previously served as CFO of Revlon (NYSE:REV), overseeing the global finance and IT operations of the top beauty brand as it grew to nearly $2 billion in annual sales. Prior to Revlon, Roberto served as CFO of The Colomer Group, a private equity-owned beauty care company with $600 million in annual revenue. He was responsible for Colomer's SAP, finance operations, integrations, acquisitions and divestments. He led the sale of Colomer to Revlon and the integration of its financial and IT operations post-merger.

Roberto holds bachelor's degrees in business administration and an MBA from ESADE Business School in Barcelona.

Bobby Jindal


Bobby Jindal has a well-earned reputation as one of America’s most successful public sector executives and one of the boldest innovators in the health care and education sectors.
Jindal used his two terms as Governor of Louisiana to rebuild and diversify the state’s economy and financial footing in the aftermath of Hurricanes Katrina and Rita.

Jindal’s agenda included top-to-bottom reformation and privatization of the state-run charity hospital and the state’s healthcare payer systems. Fiscally, Jindal reduced the state budget by 26%, reduced the state employee headcount by 30,000, and implemented the largest income tax reduction in state history. With a bipartisan consensus, Jindal implemented statewide school choice programs and moved the state from the bottom five in ethics laws to the top five, according to independent analysts.

Jindal’s dramatic rework of Louisiana’s policy structure paid measurable dividends in the form of eight credit upgrades, $60 billion in private capital investment and a ranking in the top ten in the nation for job creation and the highest ever per-capita income ranking in state history.

Despite being the nation’s youngest governor when he was elected, Jindal had been well-prepared to become the state’s CEO, with stints as the head of the state Department of Health and Hospitals, as President of the University of Louisiana System, Assistant Secretary of the U.S. Department of Health and Human Services, and Executive Director of the National Bipartisan Commission on the Future of Medicare – all before his thirtieth birthday.

Jindal also served as a U.S. Congressman. In the private sector, Jindal advised senior management of Fortune 500 firms as an associate at McKinsey & Co. In recent years, Jindal has served as a consultant to Morgan Stanley and on the boards of WellCare, Granicus, Cotton Holdings, and Brown University. He is currently an Operating Adviser for Ares Management and serves on the boards of Hornbeck Offshore Services and US Heart and Vascular.

He serves as Chairman of the Center for a Healthy America, as a member of eHealth’s Public Policy Advisory Committee, and as a member of the Bipartisan Policy Center’s Smarter, Cleaner, Faster Infrastructure Task Force. Jindal writes op-eds for the Wall Street Journal.

Jindal graduated with an ScB from Brown University with honors in Biology and Public Policy, and received an M.Litt. in Politics from Oxford University where he studied as a Rhodes Scholar.

Joan LaRovere, MD


Dr. LaRovere is Director of Innovation and Outcomes and an Attending Physician in Cardiovascular Critical Care at Boston Children’s Hospital, as well as an Assistant Professor of Pediatrics at Harvard Medical School since 2011. Before then, she was Chief of Pediatric Intensive Care and a member of the Children’s Services Management Committee at the Royal Brompton Hospital in London, where she was also a member of the faculty at Imperial College School of Medicine.

Dr. LaRovere is also the Co-Founder and Vice-President of the Virtue Foundation, an NGO with Special Consultative Status to the United Nations that seeks to provide both short-term impactful and long-term sustainable development solutions to communities across the globe. She is also an advisor and Delta V board member of the Martin Trust Center for MIT Entrepreneurship and a Healthcare Operating Partner with iSelect Fund, a venture firm investing at the intersection of nutrition and healthcare. Dr. LaRovere holds a Bachelor of Arts in Visual and Environmental Studies from Harvard University, a Master of Science in Genetics from the University of St. Andrews in Scotland, a Doctorate in Medicine from Columbia University, and an MBA from the MIT Sloan School of Management.

William Febbo


Over the last 20 years, Will has led health service, technology and finance companies, connecting key participants in the healthcare industry. As CEO and Director of OptimizeRx, he has continued to drive innovation in healthcare, and over the last several years, he has led the transformation of OptimizeRx into a leading digital health company that facilitates communication at the point-of-care for better health outcomes.

In 1999, Will co-founded and became CEO of MedPanel, a market intelligence and communication provider to the life sciences and financial industries. MedPanel was acquired in 2007 by Merriman Capital, a leading investment bank. At Merriman, he served as COO of investment banking and CEO of the firm’s Digital Capital Network. He launched pioneering digital compliance and transparency products and was part of the management team that raised more than $500 million in banking and M&A transactions.

He currently serves as a faculty member for Massachusetts Institute of Technology’s linQ program, a collaborative initiative increasing the potential of innovative biomedical research to benefit society and the economy. Will serves on board of The United Nations of Greater Boston, a non-profit focused on building a stronger network of global citizens in the Boston area.

Will earned his Bachelor of Arts in International Studies and Spanish from Dickinson College, Pennsylvania. He is fluent in Spanish, married with three children and enjoys playing soccer.

Calum MacRae, MD, PhD


Calum MacRae, M.D., Ph.D. is a cardiologist and geneticist whose clinical interests include exploring how research findings, including genomics discoveries, can be efficiently implemented into clinical care. Currently, he is Vice Chair for Scientific Innovation at the Department of Medicine at Brigham and Women’s Hospital, Professor of Medicine at Harvard Medical School, an Associate Member of the Broad Institute of Harvard and MIT and a Principal Faculty Member at the Harvard Stem Cell Institute.

His research focuses on the biology and genomics of cardiovascular disease, and he is particularly interested in the interface between technology and biomedicine. Since 2016, Dr. MacRae has been the leader of the One Brave Idea initiative to advance understanding of how technology can inform disease and disease management. This work is funded by the American Heart Association, Verily Life Sciences and AstraZeneca. He has worked with multiple technology companies on novel sensors and their utility in health and wellness and is currently the Principal Investigator of Apple’s Heart and Movement Study.

Dr. MacRae has served as a scientific advisor to various pharmaceutical, data and technology companies in the U.S. and Europe, ranging from global leaders to venture-backed companies, and has also served on the advisory boards of several investment firms. He is also a co-founder of Atman Health and Tanaist.

Dr. MacRae received his medical degree from University of Edinburgh Medical School and a Ph.D. in Human Molecular Genetics at the University of London. He is board certified in internal medicine and cardiovascular disease.

Back to top